Immunicum AB (publ) Announces Nomination Committee for AGM 2020

NEXT STORY
The global microbial identification panel market is expected to reach US$ 3,873.1 Mn in 2027 from US$ 2,288.7 Mn in 2018
PREV STORY
Phase III PEMPHIX study shows Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Trillium Therapeutics Provides Update on the Phase I Dose Escalation Study of Its CD47 Blocker TTI-622 at the ASCO20 Virtual Scientific Program

author_avatar
NASDAQ Market News

Two Centers from The US Oncology Network Adopt iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer

Prominent cancer centers expand portfolio of patient-centric treatment solutions with Xoft’s innovative, painless, scar-free ...

author_avatar
NASDAQ Market News

Bavarian Nordic Announces Interim Results for the First Nine Months of 2018

COPENHAGEN, Denmark, November 9, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced ...

author_avatar
NASDAQ Market News